Kindeva, a prominent contract development and manufacturing organization (CDMO), has announced the promotion of David Stevens from Chief Operating and Commercial Officer to the newly established role of President. This strategic move positions Stevens to oversee Kindeva’s global operations, reflecting the company’s commitment to enhancing its leadership as it navigates an evolving market landscape.
Stevens brings over 20 years of extensive experience in the CDMO industry, having successfully led teams in biologics, sterile, and drug-product manufacturing. His customer-centric approach is expected to be instrumental in driving Kindeva’s growth trajectory and operational excellence.
In his own words, Stevens expressed enthusiasm for his new role, emphasizing the importance of collaboration with both the Kindeva team and its customers to advance the company’s mission. CEO Milton Boyer highlighted Stevens’ pivotal role in Kindeva’s recent successes, indicating that this elevation will further enhance the company’s strategic focus and ability to deliver value to partners and patients globally. As Kindeva continues to innovate in drug delivery, the appointment of Stevens underscores its commitment to manufacturing solutions that meet the demands of today while paving the way for future advancements.
Use the database as your supply chain compass →
